Please wait while the formulary information is being retrieved.
Drug overview for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
Generic name: GASTRIC ENZYMES COMBO NO.3/HERBAL COMPLEX NO.212
Drug class: Digestive Enzymes
Therapeutic class: Alternative Therapy
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: GASTRIC ENZYMES COMBO NO.3/HERBAL COMPLEX NO.212
Drug class: Digestive Enzymes
Therapeutic class: Alternative Therapy
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for ABATRACE (gastric enzymes combo no.3/herbal complex no.212) have been approved by the FDA:
Indications:
None.
Professional Synonyms:
None.
Indications:
None.
Professional Synonyms:
None.
The following dosing information is available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
There are 1 contraindications.
These drug combinations generally should not be dispensed or administered to the same patient. A manufacturer label warning that indicates the contraindication warrants inclusion of a drug combination in this category, regardless of clinical evidence or lack of clinical evidence to support the contraindication.
| Drug Interaction | Drug Names |
|---|---|
| Acarbose; Miglitol/Amylase; Pancreatin SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: Digestive enzyme preparations such as amylase or pancreatin may break down acarbose(1) and miglitol.(2) CLINICAL EFFECTS: The concurrent administration digestive enzyme preparations such as amylase or pancreatin may decrease the effectiveness of acarbose(1) and miglitol.(2) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: The manufacturer of acarbose states that digestive enzymes such as amylase or pancreatin should not be taken concomitantly with acarbose.(1) The manufacturer of miglitol states that digestive enzymes such as amylase or pancreatin should not be taken concomitantly with miglitol.(2) DISCUSSION: Because digestive enzyme preparations such as amylase or pancreatin may break down acarbose(1) and miglitol(2) and decrease their effectiveness, the manufacturer of acarbose(1) and miglitol(2) state they should not be taken concomitantly with these agents. |
ACARBOSE, MIGLITOL, PRECOSE |
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Gastrointestinal obstruction |
| Meconium ileus |
There are 7 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Crohn's disease |
| Diabetes mellitus |
| Fibrosing colonopathy |
| Gastrointestinal tract surgery |
| Gout |
| Hyperuricemia |
| Short bowel syndrome |
The following adverse reaction information is available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 8 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Abdominal pain with cramps |
| Rare/Very Rare |
|---|
|
Biliary calculus Diarrhea Disorder of the digestive system Fibrosing colonopathy Gastrointestinal obstruction Hyperuricemia Nausea |
There are 9 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Abdominal distension Cough Dizziness Flatulence Headache disorder |
| Rare/Very Rare |
|---|
|
Pruritus ani Pruritus of skin Skin rash Urticaria |
The following precautions are available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for ABATRACE (gastric enzymes combo no.3/herbal complex no.212)'s list of indications:
No ICD codes found for this drug.
No ICD codes found for this drug.
Formulary Reference Tool